Log in to save to my catalogue

Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19

Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11936437

Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19

Publication information

Publisher

Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Objective: We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to investigate the short- and long-term effects of inhaled aviptadil on hospitalized, adult COVID-19 patients. Methods: A multicenter, prospective, placebo-cont...

Alternative Titles

Full title

Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11936437

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11936437

Other Identifiers

ISSN

1011-7571,1423-0151

E-ISSN

1423-0151

DOI

10.1159/000543773

How to access this item